KINFIMSA Trademark

Trademark Overview

On Wednesday, July 26, 2017, a trademark application was filed for KINFIMSA with the United States Patent and Trademark Office. The USPTO has given the KINFIMSA trademark a serial number of 79218351. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, May 30, 2025. This trademark is owned by DAIICHI SANKYO COMPANY, LIMITED. The KINFIMSA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, stroke, dyslipidemia, thrombosis, hyperphosphatemia, diabetes, cancer, oncological disease, leukemia, metastasis, bacterial infection, viral infection, pain, central nervous system diseases, neurological diseases, mood disorders, spinal cord injury, musculoskeletal disorders, osteoporosis, age-related macular degeneration, kidney disease
kinfimsa

General Information

Serial Number79218351
Word MarkKINFIMSA
Filing DateWednesday, July 26, 2017
Status709 - CANCELLED - SECTION 71
Status DateFriday, May 30, 2025
Registration Number5603660
Registration DateTuesday, November 13, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 29, 2018

Trademark Statements

Amendment to a Registration/Renewal CertificateThe drawing is amended to appear as follows: KINFIMSA and a standard character claim is inserted.
Goods and ServicesPharmaceutical preparations for the treatment and prevention of cardiovascular disease, stroke, dyslipidemia, thrombosis, hyperphosphatemia, diabetes, cancer, oncological disease, leukemia, metastasis, bacterial infection, viral infection, pain, central nervous system diseases, neurological diseases, mood disorders, spinal cord injury, musculoskeletal disorders, osteoporosis, age-related macular degeneration, kidney disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, May 30, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDAIICHI SANKYO COMPANY, LIMITED
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTokyo 103-8426
JP
Party NameDAIICHI SANKYO COMPANY, LIMITED
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo 103-8426
JP
Party NameDAIICHI SANKYO COMPANY, LIMITED
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 103-8426
JP

Trademark Events

Event DateEvent Description
Wednesday, October 25, 2017ASSIGNED TO EXAMINER
Thursday, October 26, 2017NON-FINAL ACTION WRITTEN
Thursday, October 12, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, October 18, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 24, 2017APPLICATION FILING RECEIPT MAILED
Friday, November 24, 2017REFUSAL PROCESSED BY IB
Monday, April 16, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 24, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 24, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 24, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 27, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, November 3, 2017REFUSAL PROCESSED BY MPU
Friday, November 3, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, April 16, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 24, 2018ASSIGNED TO LIE
Tuesday, May 29, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, June 21, 2018EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, November 13, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, February 13, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, February 21, 2019FINAL DISPOSITION PROCESSED
Thursday, February 21, 2019FINAL DISPOSITION NOTICE SENT TO IB
Friday, March 15, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, June 21, 2019TEAS SECTION 7 REQUEST RECEIVED
Wednesday, May 9, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 16, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 16, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, May 29, 2018PUBLISHED FOR OPPOSITION
Saturday, June 2, 2018NOTIFICATION PROCESSED BY IB
Sunday, October 7, 2018EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Thursday, July 25, 2019POST REGISTRATION ACTION MAILED - SEC. 7
Tuesday, July 23, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, August 21, 2019AMENDMENT UNDER SECTION 7 - PROCESSED
Wednesday, October 2, 2019OTQR WITHDRAWAL FROM PUBLICATION
Tuesday, October 29, 2019AMENDMENT UNDER SECTION 7 - PROCESSED
Wednesday, November 13, 2019TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Sunday, November 17, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, November 13, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 13, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 18, 2019REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD
Monday, November 13, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, May 30, 2025CANCELLED SECTION 71

Related Keywords

kinfimsa disease disorders diseases infection nervous mood neurological system spinal injury